Single Dose Jab In Covid-Hit Patients Produces Sufficient Antibody: Study

  • 4:49
  • Published On: June 14, 2021
Cinema View
Embed
At a time when India's biggest challenge has become shortage of vaccines to fight the Covid pandemic, comes an important peer-reviewed study that has big policy implications to enable larger vaccine coverage in the population. This study, carried out in Hyderabad and published in the International Journal of Infectious Diseases, says single dose vaccination in previously exposed individuals produces sufficient antibody and immune response. Padma Bhushan Dr Nageshwar Reddy tells NDTV's Uma Sudhir in an exclusive interview that it could become an important and effective strategy for India to vaccinate larger population.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
"This Was Expected": Karnataka Health Minister On JN.1 Cases In State
December 25, 2023 3:57
Maharashtra Reports 50 New COVID-19 Cases, 9 Of Them JN.1 Infections
December 25, 2023 0:46
Top Headlines Of The Day: December 24, 2023
December 24, 2023 1:20
"No Need To Panic, Need To Remain Alert": AIIMS On JN.1 Covid Variant
December 24, 2023 4:52
All You Need To Know About The New COVID Variant JN.1
December 22, 2023 9:12
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination